|
Propolis
Description
Propolis
is a resinous substance collected by worker honey bees from the growing parts
of trees and shrubs (eg., leaf buds, trunk wounds). The bees pack the propolis
on their hind legs, and carry it back to their colony, where it is combined
with beeswax and used by worker "hive" bees as a sealant and
sterilant in the colony nest. The uses take advantage of the antibacterial and
antifungal effects of propolis in protecting the colony against disease.
Propolis has also been shown to kill Bacillus larvae, the most important
bacterial disease of bees (Mlagan and Sulimanovic, 1982).
Propolis
is collected by commercial beekeepers, either by scraping the substance from
wooden hive parts, or by using specially constructed collection mats. The raw
product undergoes secondary processing to remove beeswax and other impurities
before being used in a variety of natural health care products (eg., lozenges,
tinctures, ointments, toothpaste).
History of Use
Propolis
is derived from the Greek works pro ("before") and polis
("city"), and refers to the observation made by beekeepers in ancient
times that bees often built a wall of propolis at the front entrance of their
colony (ie, "before the city‘).
Propolis
has been used by man since early times, for various purposes, and especially as
a medicine because of its antimicrobial properties (Crane, 1997). Ancient Greek
texts refer to the substance as a "cure for bruises and suppurating
sore", and in Rome propolis was used by physicians in making poultices. The
Hebrew word for propolis is tzori, and the therapeutic properties of
tzori are mentioned throughout the Old Testament. Records from 12th
century Europe describe medical preparations using propolis for the treatment
of mouth and throat infections, and dental caries (Krell, 1996).
One
of the non-medicinal uses of propolis is as a varnish, and it has been
suggested that the special properties of Stradivarius violins may be partly due
to the type of propolis used, although the claim cannot be substantiated.
Production
and Consumption
Official
records on current world propolis production are not available, although it was
estimated that in 1984 approximately 200 tonnes was traded on the world market
(Crane, 1990.) Major producers include China, Brazil, USA, Australia and
Uruguay.
Japan
is a major consumer of propolis. In 1995, the total retail market for propolis
products was estimated to be ¥20 million (NZ$282 million) (TRADENZ, 1995).
Annual New Zealand consumption is estimated at 9.9 million daily doses.
Composition
At
least 180 different compounds have been identified so far in propolis. A list
of the major chemicals occurring in propolis is given in the following table
(Krell, 1996):
|
Class
of Compound |
Group
of Components |
Amount |
|
Resins |
flavonoids,
phenolic acids and esters |
45-55% |
|
Waxes
and Fatty Acids |
beeswax
and plant origin |
25-35% |
|
Essential
Oils |
volatiles |
10% |
|
Pollen |
proteins
(16 free amino acids >1%),
arginine
and proline together 46% of total |
5% |
|
Other
Organics and Minerals |
14
trace minerals, iron and zinc most common;
ketones,
lactones, quinones, steroids, benzoic acid, vitamins, sugars |
5% |
The
most important pharmacologically active constituents in propolis are the
flavones, flavonols, and flavanones (collectively called flavonoids), and
various phenolics and aromatics. Flavonoids play a major role in plant
pigmentation.
Flavonoids are thought to account for much of the biological activity
in propolis (Grange and Davey, 1990). At least 38 flavonoids have been found in
propolis, including galangin, kaempferol, quercetin, pinocembrin, pinostrobin
and pinobanksin (Schmidt and Buchmann, 1992). Some of the phenolics include
cinnamyl alcohol, cinnamic acid, vanillin, benzyl alcohol, benzoic acid, and
caffeic and ferulic acid.
The
chemical composition of propolis is highly variable because of the broad range
of plants visited by honey bees when collecting the substance. Crane (1990)
identifies at least 67 species from which honey bees have been reported to
collect propolis material. Important sources include poplars, alders and
birches, chestnut, ash, various Prunus and willows. Variations in the
beeswax content of raw propolis also affect the chemical composition.
The
plant species available in a geographic area determine the kinds and amounts of
important compounds present in propolis. A recent study of New Zealand propolis
found that the important dihydrofavonoids pinobanksin and pinocembrin made up
approximately 70% of the flavonoids in the samples analysed (Markham, et al,
1996). A similar study of Brazilian, Uruguayan and Chinese samples showed
dihydroflavonoids to comprise less than 10% in all but one sample, which had
50%.
Studies
indicate that the plant resins collected by bees are at least partially altered
by bees prior to use in the hive (Cuellar et al, 1990). The presence of sugars
also suggest some metabolising by bees (Greenaway et al, 1987).
Human Nutrition
Propolis
has little direct nutritive value, apart from the presence of small amounts of
proteins, amino acids, minerals and sugars. Vitamins include small amounts of
A, B1, B2, B6, C and E (Ghisalberti, 1979).
Dihydroflavonoids,
like those found in propolis, have been shown to aid the human body in
absorbing Vitamin C (Bors, et al, 1995).
Propolis
is used by humans almost solely as a therapeutic. Propolis and a number of its
components exhibit a wide variety of biological and pharmacological activities
(Schmidt and Buchmann, 1992).
Therapeutic Properties
Antimicrobial Effects
Because
of its strong antimicrobial activity, propolis is often known as a
"natural antibiotic". A large number of studies have shown an
inhibitory effect on a variety of micro-organisms. The antimicrobial effects
are summarised in the following table (Krell, 1996):
|
ORGANISM |
COMMENT |
REFERENCE |
|
Bacteria |
|
|
|
Bacillus
larvae |
destroyed |
Mlagan
and Sulimanovic, 1982 |
|
B.
subtilis |
destroyed |
Meresta
and Meresta, 1985 |
|
Helicobacter
pylori |
inhibited |
Itoh,
et al, 1994 |
|
MRSA |
strong
inhibition |
Grange
and Davey, 1990 |
|
Mycobacterium
tuberculosis |
Tb |
Karimova,
1975
Grange
and Davey, 1990 |
|
Staphylococcus
sp. |
inhibited |
Chernyak,
1973 |
|
Staphylococcus
aureus |
synergistic
effect |
Kedzia
and Holderna, 1986 |
|
ORGANISM |
COMMENT |
REFERENCE |
|
Streptococcus
sp. |
inhibited |
Rojas
and Cuetara, 1990 |
|
Streptomyces |
inhibited |
Simuth
et al, 1986 |
|
S.
sobrinus, mutans, cricetus |
dental
caries |
Ikeno
et al, 1991 |
|
Saccharomyces
cerevisiae |
brewer’s
yeast |
Petri
et al, 1988 |
|
Escherichia
coli |
inhibited |
Simuth
et al, 1986 |
|
Salmonella |
potential
treatment |
Okonenko,
1986 and others |
|
Giardia
lambia |
positive
effect |
Olarin
et al, 1989 and others |
|
Bacteroides
nodosus |
reduced
foot rot |
Munoz,
1989 |
|
Klebsiella
pneumoniae |
positive
effect |
Dimov
et al, 1991 |
|
Fungi |
|
|
|
Candida
albicans |
synergistic
effect |
Holderna
and Kedzia, 1987
and
others |
|
Aspergillus
niger |
positive
effect |
Petri
et al, 1988 |
|
Botrytis
cinerea |
in
vitro fungicidal |
La
Torre et al, 1990 |
|
Ascosphaera
apis |
inhibited |
Ross,
1990 |
|
Viruses |
|
|
|
Herpes |
inhibited
in vitro |
Sosnowski,
1984 |
|
Potato
virus |
effective |
Fahmy
and Omar, 1989 |
|
Influenza
(in mice) |
reduced
mortality |
Serkedjieva,
1992 and others |
|
Newcastle
disease |
affected
virus
reproduction |
Maksimova-Todorova
et al, 1985 |
Active
components of propolis showing an antibacterial effect include pinocembrin,
galangin, caffeic acid and ferulic acid. Antifungal components include pinocembrin,
pinobanksin, caffeic acid, benzy ester, sakuranetin and pterostilbene.
Anti-viral components include caffeic acid, lutseolin and quercetin (Schmidt
and Buchmann, 1992).
Anticancer Effects
Ethanol
extracts of propolis have been found to transform human hepatic and uterine
carcinoma cells in vitro, and to inhibit their growth (Matsuno, 1992).
Substances isolated in propolis which produce this cytotoxic effect are
quercetin, caffeic acid, and clerodane diterpendoid. Clerodane diterpendoid
shows a selective toxicity to tumour cells.
Propolis
was also found to have a cytotoxic and cytostatic effect in vitro
against hamster ovary cancer cells and sarcoma-type tumours in mice (Ross,
1990). The substance has also displayed cytotoxicity on cultures of human and
animal tumour cells, including breast carcinoma, melanoma, colon, and renal
carcinoma cell lines. (Grunberger et al, 1988). The component producing these
effects was identified as caffeic acid phenethy ester.
A
substance called Artepillin C has been isolated from propolis, and has been
shown to have a cytotoxic effect on human gastric carcinoma cells, human lung
cancer cells and mouse colon carcinoma cells in vitro (Kimoto, et al,
1995).
Antioxidant Effects
The
flavonoids concentrated in propolis are powerful antioxidants, and have been
shown to be capable of scavenging free radicals and thereby protecting lipids
and other compounds such as Vitamin C from being oxidised or destroyed
(Popeskovic, et al, 1980). It is probable that active free radicals, together
with other factors, are responsible for cellular ageing and degradation in such
conditions as cardiovascular diseases, arthritis, cancer, diabetes, Parkinson
disease and Alzheimer disease.
Wound Healing and Tissue Repair Effects
Propolis
has been shown to stimulate various enzyme systems, cell metabolism,
circulation and collagen formation, as well as improve the healing of burn
wounds (Ghisalberti, 1979; Krell, 1996). These effects have been shown to be
the result of the presence of arginine in propolis (Gabrys, et al, 1986).
Propolis and aloe vera was found to be superior to standard wound treatment
products in trials on mice (Sumano-Lopez, et al, 1989).
Anaesthetic Effects
Propolis
and some of its components produce anaesthesia, which in some studies has been
shown to be 3 times as powerful as cocaine and 52 times that of procaine, when
tested in rabbit cornea (Ghisalberti, 1979). The anaesthetic effect has been
shown to be produced by pinocembrin, pinostrobin, caffeic acid esters
components in propolis (Paintz and Metzner, 1979).
The
anaesthetic effect may explain why propolis has been used for centuries in the
treatment of sore throats and mouth sores. An anaesthetising ointment for
dentistry using propolis has been patented in Europe (Sosnowski, 1984).
Effects on Immune System
Propolis
has been shown to stimulate an immune response in mice (Manolova, et al, 1987).
More recently, Japanese researchers have shown an extract of propolis to
produce a macrophage activation phenomenon related to the immune function in
humans (Moriyasu, et al, 1993). Propolis activates immune cells which produce
cytokines. The results help to explain the anti-tumour effect produced by
propolis.
Propolis
has been shown to suppress HIV-1 replication and modulate in vitro immune
responses, and, according to the authors, "May constitute a non-toxic
natural product with both anti-HIV-1, and immunoregulatory effects"
(Harish, et al, 1997).
Cardiovascular Effects
In
mice, a concentrated extract of propolis has been shown to reduce blood
pressure, produce a sedative effect, and maintain serum glucose (Kedzia et al,
1988). Dihydroflavonoids, as contained in propolis, have been shown to
strengthen capillaries (Roger, 1988), and produce antihyperlipidemic activity
(Choi, 1991). Propolis has also been shown to protect the liver against alcohol
(ethanol) and tetrachloride in rats (Coprean, et al, 1986).
Dental Care Effects
In
rats inoculated with S. sobrinus, about half of their fissures were
carious, while dental caries were significantly less in rats given water
containing propolis extract. No toxic effects of propolis on the growth of rats
were observed under experimental conditions in this study (Ikeno, et al, 1991).
Propolis has also been shown to be effective as a subsidiary treatment for
gingivitis (gum infections) and plaque (Neumann, et al, 1986). A 50% propolis
extract was found to antiseptic against pulp gangrene (Gafar, et al, 1986).
Clinical Effects on Humans
A
total of 260 steel workers suffering from bronchitis were treated for 24 days
by various methods including local and systemic regulation of the immune system
and local treatment with an ethanol extract of propolis (EEP) in a
physiological salt solution. Best results were obtained with inhalation of the
extract, together with propolis tablets (Scheller et al, 1989a). Propolis has
also shown positive effects in other otorhinolaryngologic diseases, such as
pharyngitis (Doroshenko, 1975), chronic bronchitis (Scheller, et al, 1989a),
rhinopharyngolaryngitis (Isakbaev, 1986), pharyngolaryngitis (Lin, et al,
1993), catarrh (Zommer-Urbanska et al, 1987), and rhinitis (Nunex, et al,
1988).
Sixty
students were divided into groups to test the effect of propolis on the
development of plaque and gingivitis. The results suggest that a propolis
preparation can be a useful subsidiary treatment in oral hygiene (Neumann, et
al, 1986).
A
strong immune deficiency was found in 2 patients with alveolitis fibroticans.
Treatment with a combination of the propolis, Esberitox N and calcium-magnesium
resulted in good improvements in the state of the immune system and the
clinical condition of both patients (Scheller et al, 1989 b).
Clinical
applications of propolis (1-10%) in ether or alcohol were effective against 10
superficial fungi and 9 deep-growing fungi. On oral treatment of 160 psoriasis
patients with 0.3 g propolis 3 times daily for 3 months, about one-third were
cured or greatly improved (Fang Chu, 1978).
Patients
(110) infected with ringworm were treated with 50% propolis as a unguent. In 97
patients it was found to produce excellent results (Bolshakova, 1975).
Sixty-four
patients with tibial skin ulcers, aged from 23 to 98 years, were treated using
propolis tincture in an ointment. The ointment was applied daily to the
ulcerated area, which was also treated on the periphery with antibiotic
ointments. The treatment lasted for 4-12 weeks. At the end of treatment, 19 of
the 64 treated patients exhibited no clinical signs of the condition, 19 an
improved condition (Korsun, 1983).
Patients
(229) with burns, clean wounds, infected wounds or abscesses/ulcers were
treated with a cream containing propolis at two concentrations (2% and 8%). The
higher concentration caused local intolerance in 18% of patients by day 9,
whereas the lower concentration caused symptoms in only 1.8% of patients by day
16. Burns and wounds treated with the low concentration cream healed in 11 days
on average, septic wounds in 17.5 days, 67% of ulcers in 36 days (Morales and
Garbarino, 1996).
Patients
(126) suffering external otitis, chronic mesotypanic otitis and tympan
perforation were treating with propolis solutions (5-10%). A positive
therapeutic result was reported in most cases (Matel, et al, 1973). Propolis
has also shown positive results in the treatment of acute inflammations of the
ear (Palos, et al, 1989).
Patients
(90) with cases of vagina and uterus cervix inflammation caused by S.
pyogenes were treated with 3% propolis ethanol extract. Over 50% of the
cases responded well to this treatment (Zawadzki and Scheller, 1973).
Patients
(138) suffering giardiasis were treated with propolis extracts (10-20%). In
children, 52% showed a cure at the lower dose. In adults, the cure rate was the
same as for tinidazole, an antiprotozoan drug, at the 20% extract, and 60% vrs.
40% for tindazole at a higher concentration (30% propolis extract) (Mirayes, et
al, 1988).
The
diverse use of propolis in clinical trials shows that its therapeutic efficacy
lies mainly in diseases caused by microbial contaminations (Marcucci, 1995).
Adverse Effects
Propolis
has been shown not to be toxic to humans or mammals unless very large
quantities are administered (Ghisalberti, 1979). Some of its constituent
flavones, eg., quercetin, might be mutagenic by the Ames test, but mutagenicityper se for propolis has not been reported (Schmidt and Buchmann, 1992).
Contact
dermatitis is a well-documented allergic reaction to propolis (Hausen et al,
1987). Dermatitis can be produced by skin contact with raw propolis, as well as
propolis extracts and products containing extracts, and this can cause problems
for some beekeepers and other users. Caffeic acid and its derivatives have been
identified as the major allergenic agent (Hashimoto, et al, 1988). Dermatitis
is relieved once the skin is no longer in contact with the propolis product. It
is therefore recommended that with all preparations intended for human use,
usage is ceased whenever there is an allergic reaction.
Very
few other adverse reactions to propolis have been documented in the literature,
and the product is considered generally not to be harmful (Schmidt and
Buchmann, 1992).
Commercial Use
Raw
propolis is collected by beekeepers and sold in bulk to companies that refine
the product and turn it into usable extracts. Most commercial uses of propolis
are based on preparations made up from these extracts. Methods include ethanol
extraction (EEP), glycol extraction (GEP), aqueous (water) extraction (AEP),
oil extraction (OEP), and water-soluble derivatives (WSD). Where solvents are
used, reduction or elimination of the solvent is necessary, either by
freeze-drying, vacuum distillation, or evaporation. Extraction is used to
remove the beeswax which is mixed with the propolis by the bees during use in
the hive, as well as other non-active components such as resinous-balsam
substances.
Main
commercial uses of propolis are as a dietary supplement and therapeutic.
Propolis is sold in tablets (singularly, or in combination with other
substances such as pollen, royal jelly and non-hive products), and tinctures,
and as an ingredient in lozenges, skin creams, shampoos, lipsticks, toothpastes
and mouthwashes. Tinctures and lozenges are popular treatment for sore throats,
and tinctures are often used to treat cuts, mouth sores and skin rashes. The
antioxidant, antimicrobial and antifungal activities of propolis also offer
opportunities in food technology. In Japan, the use of propolis is permitted as
a preservative in frozen fish (Krell, 1996).
Propolis
is a stable product, but should nevertheless be stored in airtight containers
in the dark, preferably away from excessive and direct heat. Propolis does not
lose much of its antibiotic activity, even when stored for 12 months or longer.
Propolis and its extract function as a mild preservative due to their
antioxidant and antimicrobial activities and thus may actually prolong the
shelf life of some products (Krell, 1996).
Food Safety
Because
of its antioxidant and antimicrobial activities, microbial contamination is not
considered to be a problem with propolis, either in the raw form, or as
extracts.
Concentrations
of lead above maximum allowable levels for food products have been found in
propolis. Studies have shown that lead levels may be reduced by placement of
hives away from areas with heavy air pollution and the use of oil based paints
on hive parts (Alcici, 1996). Propolis destined for commercial use should be
routinely tested for lead concentration.
Quality Control
No
international standards exist for propolis. Official standards exist for
propolis in several East European countries. Maximum and minimum limits for
certain chemicals are set, but few standardised tests are available to
determine the biological activities of various components.
|